• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

固定性药疹的局部激发试验。

Topical provocation of fixed drug eruption.

作者信息

Alanko K, Stubb S, Reitamo S

出版信息

Br J Dermatol. 1987 Apr;116(4):561-7. doi: 10.1111/j.1365-2133.1987.tb05879.x.

DOI:10.1111/j.1365-2133.1987.tb05879.x
PMID:2953388
Abstract

To determine whether topical provocation could be used for the diagnosis of fixed drug eruption (FDE) instead of systemic provocation, we applied the suspected drug at various concentrations (1-10%) in either petrolatum, 94% ethanol or dimethyl sulphoxide (DMSO) as an open test on both clinically normal skin and on previous FDE lesions in 24 patients with established FDE due to phenazone salicylate, a sulphonamide, doxycycline, trimethoprim, chlormezanone, a barbiturate, or carbamazepine. In 18 of the 24 patients, local provocation of FDE was seen at sites or previous eruption but never on clinically normal skin. With some drugs, e.g. phenazone salicylate, positive provocation of FDE was seen with all the vehicles used; with sulphamethoxazole and trimethoprim, a positive result was seen only in DMSO. To study cross-reactions to other phenazone derivatives in patients with an FDE caused by phenazone salicylate, we applied topical phenazone, aminophenazone and propyphenazone to sites of previous FDE lesions in three patients. In all three, a positive reaction was seen with phenazone, but only one patient showed positive results with aminophenazone and propyphenazone. The present study suggests that topical provocation is useful with several drugs causing FDE. Testing should always be performed on sites of previous FDE, and the sensitivity of the open topical testing can be increased in certain cases by using a vehicle which increases penetration of the drug.

摘要

为了确定是否可以使用局部激发试验而非全身激发试验来诊断固定性药疹(FDE),我们在24例因非那宗水杨酸盐、磺胺类药物、强力霉素、甲氧苄啶、氯美扎酮、巴比妥类药物或卡马西平导致确诊FDE的患者中,将可疑药物以1% - 10%的不同浓度分别混入凡士林、94%乙醇或二甲基亚砜(DMSO)中,对临床正常皮肤和既往FDE皮损部位进行开放性试验。24例患者中有18例在既往皮疹部位出现了FDE局部激发反应,但在临床正常皮肤上未出现。对于某些药物,如非那宗水杨酸盐,使用所有载体均可见FDE阳性激发反应;对于磺胺甲恶唑和甲氧苄啶,仅在DMSO中出现阳性结果。为研究因非那宗水杨酸盐导致FDE的患者对其他非那宗衍生物的交叉反应,我们对3例患者既往FDE皮损部位外用非那宗、氨基非那宗和丙基非那宗。所有3例患者对非那宗均出现阳性反应,但仅1例患者对氨基非那宗和丙基非那宗出现阳性结果。本研究提示,局部激发试验对多种导致FDE的药物有用。试验应始终在既往FDE皮损部位进行,在某些情况下,通过使用能增加药物渗透性的载体可提高开放性局部试验的敏感性。

相似文献

1
Topical provocation of fixed drug eruption.固定性药疹的局部激发试验。
Br J Dermatol. 1987 Apr;116(4):561-7. doi: 10.1111/j.1365-2133.1987.tb05879.x.
2
Topical provocation of fixed drug eruption. A study of 30 patients.固定性药疹的局部激发试验。30例患者的研究。
Contact Dermatitis. 1994 Jul;31(1):25-7. doi: 10.1111/j.1600-0536.1994.tb01900.x.
3
Topical provocation in 27 cases of cotrimoxazole-induced fixed drug eruption.27例复方新诺明所致固定性药疹的局部激发试验
Contact Dermatitis. 1999 Oct;41(4):185-9. doi: 10.1111/j.1600-0536.1999.tb06127.x.
4
Fixed drug eruption: topical provocation and subsequent phenomena.
J Coll Physicians Surg Pak. 2006 Dec;16(12):747-50.
5
Provocation tests in a chlormezanone-induced fixed drug eruption.氯美扎酮诱发的固定性药疹激发试验
DICP. 1991 Jun;25(6):604-5. doi: 10.1177/106002809102500608.
6
Topical provocation in fixed drug eruption due to metamizol and naproxen.由安乃近和萘普生引起的固定性药疹中的局部激发试验。
Clin Exp Dermatol. 2004 Jul;29(4):419-22. doi: 10.1111/j.1365-2230.2004.01537.x.
7
Fixed drug eruption: state of the art.固定性药疹:最新进展
J Dtsch Dermatol Ges. 2008 Mar;6(3):181-8. doi: 10.1111/j.1610-0387.2007.06491.x. Epub 2007 Dec 10.
8
Drug related clinical pattern in fixed drug eruption.固定性药疹的药物相关临床模式。
Eur J Dermatol. 2000 Jun;10(4):288-91.
9
Suction blister fluid histamine in fixed drug eruption.固定性药疹中的抽吸水疱液组胺
Acta Derm Venereol. 1992;72(2):89-91.
10
Fixed drug eruption and intradermal provocation tests.
J Coll Physicians Surg Pak. 2008 Dec;18(12):736-9.

引用本文的文献

1
Nimesulide-Induced Fixed Drug Eruption Followed by Etoricoxib-Induced Fixed Drug Eruption: An Unusual Case Report and Review of the Literature.尼美舒利诱发的固定性药疹继以依托考昔诱发的固定性药疹:一例罕见病例报告及文献复习
J Clin Med. 2024 Mar 10;13(6):1583. doi: 10.3390/jcm13061583.
2
The Role of Patch Testing in Evaluating Delayed Hypersensitivity Reactions to Medications.斑贴试验在评估药物迟发性超敏反应中的作用。
Clin Rev Allergy Immunol. 2022 Jun;62(3):548-561. doi: 10.1007/s12016-022-08924-2. Epub 2022 Feb 3.
3
Stamping a Case of Cutaneous Adverse Drug Reaction: Proving Beyond Causality Assessment.
一例皮肤药物不良反应的认定:超越因果关系评估的证明
Indian J Dermatol. 2018 Mar-Apr;63(2):99-106. doi: 10.4103/ijd.IJD_580_17.
4
Skin testing and patch testing in non-IgE-mediated drug allergy.非 IgE 介导药物过敏的皮肤试验和斑贴试验。
Curr Allergy Asthma Rep. 2014 Jun;14(6):442. doi: 10.1007/s11882-014-0442-8.
5
Fluconazole-induced Fixed Drug Eruption.氟康唑诱发的固定型药疹。
J Clin Aesthet Dermatol. 2013 Mar;6(3):44-5.
6
Clinical Management of Nonsteroidal Anti-inflammatory Drug Hypersensitivity.非甾体抗炎药过敏的临床管理。
World Allergy Organ J. 2008 Feb;1(2):29-33. doi: 10.1097/WOX.0b013e3181625db2.
7
Fixed drug eruption induced by atenolol.由阿替洛尔引起的固定性药物疹。
Clin Cosmet Investig Dermatol. 2009 Apr 24;1:37-9.
8
Patch testing for the diagnosis of anticonvulsant hypersensitivity syndrome: a systematic review.用于诊断抗惊厥药超敏反应综合征的斑贴试验:一项系统评价
Drug Saf. 2009;32(5):391-408. doi: 10.2165/00002018-200932050-00003.
9
Management of cutaneous drug reactions.皮肤药物反应的管理。
Curr Allergy Asthma Rep. 2002 Jan;2(1):26-33. doi: 10.1007/s11882-002-0034-x.